A new logistic regression derived combined index for early prediction of in-hospital mortality in COVID-19 patients
IF 0.1
Q4 RESPIRATORY SYSTEM
Stefania Bassu, Elena Masotto, Chiara Sanna, Verdiana Muscas, Dario Argiolas, C. Carru, P. Pirina, A. Mangoni, P. Paliogiannis, A. Fois, A. Zinellu
{"title":"A new logistic regression derived combined index for early prediction of in-hospital mortality in COVID-19 patients","authors":"Stefania Bassu, Elena Masotto, Chiara Sanna, Verdiana Muscas, Dario Argiolas, C. Carru, P. Pirina, A. Mangoni, P. Paliogiannis, A. Fois, A. Zinellu","doi":"10.23736/s2784-8477.22.02007-1","DOIUrl":null,"url":null,"abstract":"BACKGROUND: While the type and the number of treatments for Coronavirus Disease 2019 (COVID-19) have substantially evolved since the start of the pandemic a significant number of hospitalized patients continue to succumb. This requires ongoing research in the development and improvement of early risk stratification tools. METHOD(S): We developed a prognostic score using epidemiological, clinical, laboratory, and treatment variables collected on admission in 130 adult COVID-19 patients followed until in-hospital death (N.=38) or discharge (N.=92). Potential variables were selected via multivariable logistic regression modelling conducted using a logistic regression univariate analysis to create a combined index. RESULT(S): Age, Charlson Comorbidity Index, P/F ratio, prothrombin time, C-reactive protein and troponin were the selected variables. AUROC indicated that the model had an excellent AUC value (0.971, 95% CI 0.926 to 0.993) with 100% sensitivity and 83% specificity for in-hospital mortality. The Hosmer-Lemeshow calibration test yielded non-significant P values (chi2=1.79, P=0.99) indicates good calibration. CONCLUSION(S): This newly developed combined index could be useful to predict mortality of hospitalized COVID-19 patients on admission.Copyright © 2022 EDIZIONI MINERVA MEDICA.","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"45 1","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Respiratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/s2784-8477.22.02007-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND: While the type and the number of treatments for Coronavirus Disease 2019 (COVID-19) have substantially evolved since the start of the pandemic a significant number of hospitalized patients continue to succumb. This requires ongoing research in the development and improvement of early risk stratification tools. METHOD(S): We developed a prognostic score using epidemiological, clinical, laboratory, and treatment variables collected on admission in 130 adult COVID-19 patients followed until in-hospital death (N.=38) or discharge (N.=92). Potential variables were selected via multivariable logistic regression modelling conducted using a logistic regression univariate analysis to create a combined index. RESULT(S): Age, Charlson Comorbidity Index, P/F ratio, prothrombin time, C-reactive protein and troponin were the selected variables. AUROC indicated that the model had an excellent AUC value (0.971, 95% CI 0.926 to 0.993) with 100% sensitivity and 83% specificity for in-hospital mortality. The Hosmer-Lemeshow calibration test yielded non-significant P values (chi2=1.79, P=0.99) indicates good calibration. CONCLUSION(S): This newly developed combined index could be useful to predict mortality of hospitalized COVID-19 patients on admission.Copyright © 2022 EDIZIONI MINERVA MEDICA.
基于logistic回归的新型COVID-19住院死亡率早期预测联合指标
背景:自大流行开始以来,尽管2019冠状病毒病(COVID-19)的治疗类型和数量发生了重大变化,但仍有大量住院患者死亡。这需要在开发和改进早期风险分层工具方面进行持续研究。方法:我们利用入院时收集的流行病学、临床、实验室和治疗变量,对130例成年COVID-19患者进行预后评分,直至院内死亡(38例)或出院(92例)。通过多变量logistic回归建模选择潜在变量,采用单变量logistic回归分析创建组合指数。结果(S):年龄、Charlson合并症指数、P/F比、凝血酶原时间、c反应蛋白和肌钙蛋白是选择的变量。AUROC结果表明,该模型对院内死亡率具有良好的AUC值(0.971,95% CI 0.926 ~ 0.993),敏感性为100%,特异性为83%。Hosmer-Lemeshow校准检验P值不显著(ch2 =1.79, P=0.99),表明校准良好。结论:该综合指标可用于预测COVID-19住院患者入院时的死亡率。版权所有©2022 EDIZIONI MINERVA MEDICA。
本文章由计算机程序翻译,如有差异,请以英文原文为准。